CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitro

By Eaglings V. A.   Wiltshire H.   Whitcombe I. W. A.   Back D. J.  

Xenobiotica, Vol. 32, Iss. 1, 2002-01 ,pp. : 1-17

Informa Healthcare

Access to resources Recommend Favorite

Design of a folding inhibitor of the HIV-1 protease

By Tiana G.   Broglia R. A.   Sutto L.   Provasi D.  

Molecular Simulation, Vol. 31, Iss. 11, 2005-09 ,pp. : 765-771

Taylor & Francis Ltd

Access to resources Recommend Favorite

Comparative analysis of substrate and inhibitor interactions with CYP3A4 and CYP3A5

By Soars M. G.   Grime K.   Riley R. J.  

Xenobiotica, Vol. 36, Iss. 4, 2006-04 ,pp. : 287-299

Informa Healthcare

Access to resources Recommend Favorite

Ilaprazole, a new proton pump inhibitor, is primarily metabolized to ilaprazole sulfone by CYP3A4 and 3A5

By Seo Kyung-Ah   Lee So-Jeong   Kim Kwon-Bok   Bae Soo Kyung   Liu Kwang-Hyeon   Kim Dong-Hyun   Shin Jae-Gook  

Xenobiotica, Vol. 42, Iss. 3, 2012-03 ,pp. : 278-284

Informa Healthcare

Access to resources Recommend Favorite

Disposition of LY333531, a selective protein kinase C β inhibitor, in the Fischer 344 rat and beagle dog

By Burkey J. L.   Campanale K. M.   O'Bannon D. D.   Cramer J. W.   Farid N. A.  

Xenobiotica, Vol. 32, Iss. 11, 2002-11 ,pp. : 1045-1052

Informa Healthcare

Access to resources Recommend Favorite